1. Home
  2. CCLD vs CNTX Comparison

CCLD vs CNTX Comparison

Compare CCLD & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$2.88

Market Cap

123.0M

Sector

Technology

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$2.38

Market Cap

132.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCLD
CNTX
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.0M
132.3M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
CCLD
CNTX
Price
$2.88
$2.38
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$1.50
$6.00
AVG Volume (30 Days)
274.6K
2.2M
Earning Date
03-12-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$114,315,000.00
N/A
Revenue This Year
$8.58
N/A
Revenue Next Year
$12.06
N/A
P/E Ratio
$38.08
N/A
Revenue Growth
2.97
N/A
52 Week Low
$1.14
$0.49
52 Week High
$4.75
$2.28

Technical Indicators

Market Signals
Indicator
CCLD
CNTX
Relative Strength Index (RSI) 41.53 82.62
Support Level $2.85 $1.39
Resistance Level $3.08 $1.65
Average True Range (ATR) 0.10 0.19
MACD -0.00 0.07
Stochastic Oscillator 6.68 98.49

Price Performance

Historical Comparison
CCLD
CNTX

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: